Evidence map›Paper›PMID 31324658›Full record

ArticleMolecular & cellular proteomics : MCP2019

Delta-S-Cys-Albumin: A Lab Test that Quantifies Cumulative Exposure of Archived Human Blood Plasma and Serum Samples to Thawed Conditions.

Joshua W Jeffs, Nilojan Jehanathan, Stephanie M F Thibert, Shadi Ferdosi, Linda Pham, Zachary T Wilson, Christian Breburda, Chad R Borges

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Joshua W JeffsSchool of Molecular Sciences and The Biodesign Institute at Arizona State University, Tempe, AZ 85287.
Nilojan JehanathanSchool of Molecular Sciences and The Biodesign Institute at Arizona State University, Tempe, AZ 85287.
Stephanie M F ThibertSchool of Molecular Sciences and The Biodesign Institute at Arizona State University, Tempe, AZ 85287.
Shadi FerdosiSchool of Molecular Sciences and The Biodesign Institute at Arizona State University, Tempe, AZ 85287.
Linda PhamMaricopa Integrated Health System, Phoenix, AZ 85008.
Zachary T WilsonMaricopa Integrated Health System, Phoenix, AZ 85008; University of Arizona College of Medicine, Phoenix, AZ 85004.
Christian BreburdaMaricopa Integrated Health System, Phoenix, AZ 85008; University of Arizona College of Medicine, Phoenix, AZ 85004.
Chad R BorgesSchool of Molecular Sciences and The Biodesign Institute at Arizona State University, Tempe, AZ 85287. Electronic address: chad.borges@asu.edu.
Arizona State University · USUniversity of Arizona · USValleywise Health · US

Funding

Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum IntegrityR33CA217702 · NCI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI BORGES, CHAD R · 2018 to 2020
$1.1M
NCI NIH HHS R33 CA217702
6 · The paper itself

Abstract

Exposure of blood plasma/serum (P/S) to thawed conditions (> -30 °C) can produce biomolecular changes that skew measurements of biomarkers within archived patient samples, potentially rendering them unfit for molecular analysis. Because freeze-thaw histories are often poorly documented, objective methods for assessing molecular fitness before analysis are needed. We report a 10-μl, dilute-and-shoot, intact-protein mass spectrometric assay of albumin proteoforms called "ΔS-Cys-Albumin" that quantifies cumulative exposure of archived P/S samples to thawed conditions. The relative abundance of S-cysteinylated (oxidized) albumin in P/S increases inexorably but to a maximum value under 100% when samples are exposed to temperatures > -30 °C. The difference in the relative abundance of S-cysteinylated albumin (S-Cys-Alb) before and after an intentional incubation period that drives this proteoform to its maximum level is denoted as ΔS-Cys-Albumin. ΔS-Cys-Albumin in fully expired samples is zero. The range (mean ± 95% CI) observed for ΔS-Cys-Albumin in fresh cardiac patient P/S (

Indexed as

BiomarkersCysteineFreezingHumansMass SpectrometryPlasmaSerumSerum AlbuminBiomarkersCysteineSerum Albuminbiobankingcysteinecystineplasma or serum analysispost-translational modificationsquality assurancequality control and metricss-cysteinylated albuminSerum/plasma

Identifiers

PMID31324658
PMCPMC6773563
OpenAlexW2962844841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.